Literature DB >> 30472174

Primary Thrombectomy Versus Combined Mechanical Thrombectomy and Intravenous Thrombolysis in Large Vessel Occlusion Acute Ischemic Stroke.

Mariana Guimarães Rocha1, Andreia Carvalho2, Marta Rodrigues3, André Cunha3, Sofia Figueiredo2, António Martins de Campos2, Tiago Gregório4, Ludovina Paredes4, Miguel Veloso5, Pedro Barros5, Sérgio Castro3, Manuel Ribeiro3, Henrique Costa5.   

Abstract

Mechanical thrombectomy (MT) in combination with intravenous thrombolysis (IVT) is the standard of care for patients with acute ischemic stroke with anterior circulation large vessel occlusion. The particular benefit of IVT in these patients is unknown. We performed a retrospective analysis of patients submitted to MT at our center between January 2015 and June 2017. Functional outcome was prospectively assessed using modified Rankin scale (mRS) at 3 months. A total of 234 patients were enrolled, 152 (65%) in the combined treatment group and 82 (35%) in the direct MT group. Patients receiving combined treatment had a higher frequency of intracranial internal carotid artery occlusion (48 [31.6%] versus 16 [19.5%], P = .048) and significantly less strokes of cardioembolic etiology (72 [47.4%] versus 57 [69.5%], P = .01). Other baseline characteristics did not differ between the 2 groups. Good functional outcome at 3 months (mRS 0-2) was trending toward being higher in patients in the combined treatment group (98 [64.9%] versus 42 [52.5%], P = .066). Rates of symptomatic intracranial hemorrhage (5 [3.3%] versus 4 [4.9%], P = .723) and mortality (15 [9.9%] versus 14 [17.5%], P = .099) did not differ between groups. In multivariate logistic regression analysis, we did not find a statistically significant association between the use of IVT and any of the outcomes studied. Our results suggest that combined treatment carries similar effectiveness and safety than direct MT. Randomized controlled trials regarding this subject are warranted.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Primary mechanical thrombectomy; stroke; thrombectomy; thrombolysis

Mesh:

Substances:

Year:  2018        PMID: 30472174     DOI: 10.1016/j.jstrokecerebrovasdis.2018.11.002

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

Review 1.  Outcomes of mechanical thrombectomy with pre-intravenous thrombolysis: a systematic review and meta-analysis.

Authors:  Lu Fan; Lin Zang; Xiaodong Liu; Jian Wang; Jianting Qiu; Yujie Wang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

2.  Clinical and Neuroimaging Outcomes of Direct Thrombectomy vs Bridging Therapy in Large Vessel Occlusion: Analysis of the SELECT Cohort Study.

Authors:  Amrou Sarraj; James Grotta; Gregory W Albers; Ameer E Hassan; Spiros Blackburn; Arthur Day; Clark Sitton; Michael Abraham; Chunyan Cai; Mark Dannenbaum; Deep Pujara; William Hicks; Ronald Budzik; Nirav Vora; Ashish Arora; Bader Alenzi; Wondwossen G Tekle; Haris Kamal; Osman Mir; Andrew D Barreto; Maarten Lansberg; Rishi Gupta; Sheryl Martin-Schild; Sean Savitz; Georgios Tsivgoulis
Journal:  Neurology       Date:  2021-04-19       Impact factor: 11.800

3.  In-Hospital Intravenous Thrombolysis Offers No Benefit in Mechanical Thrombectomy in Optimized Tertiary Stroke Center Setting.

Authors:  Juha-Pekka Pienimäki; Jyrki Ollikainen; Niko Sillanpää; Sara Protto
Journal:  Cardiovasc Intervent Radiol       Date:  2020-12-22       Impact factor: 2.740

4.  Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta-Analysis.

Authors:  Houwei Du; Hanhan Lei; Gareth Ambler; Shuangfang Fang; Raoli He; Qilin Yuan; David J Werring; Nan Liu
Journal:  J Am Heart Assoc       Date:  2021-11-15       Impact factor: 6.106

5.  Direct versus Bridging Mechanical Thrombectomy in Elderly Patients with Acute Large Vessel Occlusion: A Multicenter Cohort Study.

Authors:  Yating Jian; Lili Zhao; Baixue Jia; Xu Tong; Tao Li; Yulun Wu; Xiaoya Wang; Zhen Gao; Yu Gong; Xuelei Zhang; Huqing Wang; Ru Zhang; Lei Zhang; Zhongrong Miao; Guilian Zhang
Journal:  Clin Interv Aging       Date:  2021-07-05       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.